Pharmaceutical

NuGel by Shaperon for Sepsis: Likelihood of Approval

Jun 11, 2023

NuGel is under clinical development by Shaperon and currently in Phase I for Sep...

TAS-117 by Taiho Pharmaceutical for Chondrosarcoma: Lik...

Jun 11, 2023

TAS-117 is under clinical development by Taiho Pharmaceutical and currently in P...

VEDVDox by ImmunityBio for Recurrent Glioblastoma Multi...

Jun 11, 2023

VEDVDox is under clinical development by ImmunityBio and currently in Phase I fo...

CIGB-128 by Center for Genetic Engineering and Biotechn...

Jun 11, 2023

CIGB-128 is under clinical development by Center for Genetic Engineering and Bio...

Influenza vaccine 2 by Shanghai Institute of Biological...

Jun 11, 2023

Influenza vaccine 2 is under clinical development by Shanghai Institute of Biolo...

PB-357 by Puma Biotechnology for Breast Cancer: Likelih...

Jun 11, 2023

PB-357 is under clinical development by Puma Biotechnology and currently in Phas...

RZ-358 by Rezolute for Hyperinsulinemia: Likelihood of ...

Jun 11, 2023

RZ-358 is under clinical development by Rezolute and currently in Phase II for H...

STAT+: Chamber of Commerce tries new legal arguments to challenge Medicare drug-price negotiation

STAT+: Chamber of Commerce tries new legal arguments to...

Jun 10, 2023

The Chamber of Commerce lawsuit is the second to challenge the drug-price negoti...

Top health officials call for more research to support fentanyl test strips

Top health officials call for more research to support ...

Jun 10, 2023

Research on the most effective use of fentanyl test strips could be useful as ot...

STAT+: FDA panel unanimously endorses Eisai’s Alzheimer’s drug

STAT+: FDA panel unanimously endorses Eisai’s Alzheimer...

Jun 10, 2023

The vote in favor of expanding the approval of Alzheimer's treatment Leqembi fur...

STAT+: Drug companies and pharmacies reach $17.3 billion settlement over opioid crisis

STAT+: Drug companies and pharmacies reach $17.3 billio...

Jun 10, 2023

Drug companies and pharmacies have reached a $17.3 billion settlement over the o...

FDA’s letter to medical device maker iRhythm is a warning for the industry

FDA’s letter to medical device maker iRhythm is a warni...

Jun 10, 2023

The FDA issued a warning to device maker iRhythm for marketing its product for “...

STAT+: ‘Stung’ by Pear’s bankruptcy, a state Medicaid program pauses on digital therapeutics

STAT+: ‘Stung’ by Pear’s bankruptcy, a state Medicaid p...

Jun 10, 2023

"It would be hard for me to convince my leadership to take that leap again so so...

Opinion: Why we created a chatbot to help people at risk for eating disorders

Opinion: Why we created a chatbot to help people at ris...

Jun 10, 2023

The grim reality is there will never be enough trained therapists to meet the de...

STAT Virtual Event – Decoding Clinical Trials: How to Spot and Avoid Clinical Trial Risk

STAT Virtual Event – Decoding Clinical Trials: How to S...

Jun 10, 2023

Join Frank David and Ken Getz to discuss the practical factors that add risk to ...

STAT+: Trailing other sickle cell drug makers, Editas still sees opportunity for its CRISPR therapy

STAT+: Trailing other sickle cell drug makers, Editas s...

Jun 10, 2023

"The patient community, all payers, all regulatory agencies, they all welcome mu...